Nano-X Imaging Ltd. signs exclusive distribution agreement with Adriamed for Nanox.ARC in Serbia, Montenegro, and Bosnia and Herzegovina

Reuters01-14 21:30
<a href="https://laohu8.com/S/NNOX">Nano-X Imaging Ltd.</a> signs exclusive distribution agreement with Adriamed for Nanox.ARC in Serbia, Montenegro, and Bosnia and Herzegovina

Nano-X Imaging Ltd. announced a new collaboration with Adriamed d.o.o. Beograd, appointing Adriamed as the exclusive partner for marketing, distribution, installation, and support of the Nanox.ARC system and related services in Serbia, Montenegro, and Bosnia and Herzegovina. This agreement will bring the Nanox.ARC, a multi-source digital tomosynthesis system, to healthcare providers in the region. The engagement is part of Nanox's ongoing commercial expansion in Europe and follows previous collaborations in other European markets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nano-X Imaging Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001159233-en) on January 14, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment